Rongzhi Wang, Rhiannon D Reed, Griffin Price, Peter Abraham, Marshall Lewis, Jessica Liu McMullin, Paul MacLennan, Cozette Killian, Jayme E Locke, Song Ong, Vineeta Kumar, Andrea Gillis, Brenessa Lindeman, Herbert Chen, Jessica Fazendin
BACKGROUND: Hyperparathyroidism (HPT) and malignancy are the most common causes of hypercalcemia. Among kidney transplant (KT) recipients, hypercalcemia is mostly caused by tertiary HPT. Persistent tertiary HPT after KT is associated with allograft failure. Previous studies on managing tHPT were subjected to survivor treatment selection bias; as such, the impact of tertiary HPT treatment on allograft function remained unclear. We aim to assess the association between hypercalcemic tertiary HPT treatment and kidney allograft survival...
November 24, 2023: Oncologist